Navigation Links
Neogen COO resigns

LANSING, Mich., July 18, 2014 /PRNewswire/ -- Neogen Corporation (Nasdaq: NEOG) announced today that Stephen Snyder, Neogen's chief operating officer and president, has resigned, effective July 31, 2014. The company said he will work as a consultant going forward on special projects. His resignation is for personal matters.

Snyder has been in this position since September 2013. On an interim basis, his duties will be fulfilled by James Herbert, who has been Neogen's chief executive officer since the company's founding. Neogen's Board of Directors, with Herbert's leadership, is actively recruiting for Snyder's replacement.

Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division is a leader in the development of animal genomics, along with the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals, veterinary instruments, wound care and disinfectants.

CONTACT: Steven J. Quinlan, Vice President & CFO
Neogen Corporation, 517/372-9200

SOURCE Neogen Corporation
Copyright©2014 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Neogen licenses Cargill patents
2. Neogen acquires Chem-Tech
3. Neogen reports second quarter results
4. Neogen acquires Prima Tech
5. Neogen shares to be priced Oct. 31
6. Neogen shares begin post-split trading
7. Neogen reports 18% revenue increase
8. Neogen announces 1st quarter results conference call
9. Neogen launches comprehensive dairy heifer genomic test
10. Neogen announces Bohannon retirement, successor named
11. Neogen launches comprehensive cattle genomic test
Post Your Comments:
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... Ky. , June 23, 2016 ... two Phase 1 clinical trials of its complement ... placebo-controlled, single and multiple ascending dose studies designed ... pharmacodynamics (PD) of subcutaneous injection in healthy adult ... subcutaneously (SC) either as a single dose (ranging ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... is exhibiting at the Pennsylvania Convention Center and will showcase its product’s latest ... ClinCapture will also be presenting a scientific poster on Disrupting Clinical Trials in ...
(Date:6/23/2016)... 23, 2016 adds ... to its pharmaceuticals section with historic and forecast ... much more. Complete report on the ... profiling 15 companies and supported with 261 tables ... . The Global Cell Culture ...
Breaking Biology Technology:
(Date:5/12/2016)... 12, 2016 , a brand ... overview results from the Q1 wave of its quarterly ... was consumers, receptivity to a program where they would ... health insurance company. "We were surprised to ... Michael LaColla , CEO of Troubadour Research, "primarily ...
(Date:4/26/2016)... and LONDON , April ... part of EdgeVerve Systems, a product subsidiary of ... today announced a partnership to integrate the Onegini ...      (Logo: ) ... their customers enhanced security to access and transact ...
(Date:4/14/2016)... , April 14, 2016 ... and Malware Detection, today announced the appointment of ... the new role. Goldwerger,s leadership appointment comes ... the heels of the deployment of its platform at ... behavioral biometric technology, which discerns unique cognitive and physiological ...
Breaking Biology News(10 mins):